NCT05509881View on ClinicalTrials.gov

Continuous Glucose Monitoring in Dialysis Patients to Overcome Dysglycemia Trial

NARecruitingINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

December 12, 2023

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
HemodialysisDiabete MellitusContinuous Glucose Monitoring
Interventions
DEVICE

Continuous glucose monitoring (CGM)

"Patients in the CGM arm will undergo continuous real-time unblinded CGM using Dexcom CGM devices."

DEVICE

Usual care (Self-monitored blood glucose)

Patients in the usual care arm will conduct self-monitored blood glucose at least 4 times/day.

Trial Locations (1)

92868

RECRUITING

University of California, Irvine, Orange

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of California, Irvine

OTHER